ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 33 filers reported holding ONCOLYTICS BIOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 99 | +83.3% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 54 | -99.8% | 0.00% | – |
| Q2 2022 | $34,000 | +385.7% | 35,362 | +586.1% | 0.00% | – |
| Q4 2021 | $7,000 | +133.3% | 5,154 | +294.6% | 0.00% | – |
| Q3 2021 | $3,000 | -57.1% | 1,306 | -49.8% | 0.00% | – |
| Q2 2021 | $7,000 | -91.8% | 2,600 | -88.4% | 0.00% | – |
| Q1 2021 | $85,000 | +372.2% | 22,465 | +190.5% | 0.00% | – |
| Q4 2020 | $18,000 | +1700.0% | 7,734 | +2309.3% | 0.00% | – |
| Q3 2020 | $1,000 | -95.0% | 321 | -96.9% | 0.00% | – |
| Q2 2020 | $20,000 | +122.2% | 10,459 | +443.6% | 0.00% | – |
| Q4 2019 | $9,000 | +200.0% | 1,924 | -57.2% | 0.00% | – |
| Q3 2019 | $3,000 | +50.0% | 4,500 | +336.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 1,032 | +391.4% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 210 | -18.9% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 259 | +23.3% | 0.00% | – |
| Q2 2018 | $1,000 | – | 210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 5,302,036 | $11,558,438 | 2.33% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 201,453 | $449,240 | 0.06% |
| BRAVE ASSET MANAGEMENT INC | 25,000 | $54,927 | 0.02% |
| Ausdal Financial Partners, Inc. | 20,000 | $43,600 | 0.01% |
| HEADINVEST, LLC | 11,534 | $24,106 | 0.01% |
| Cedar Mountain Advisors, LLC | 5,651 | $12,319 | 0.00% |
| Long Focus Capital Management, LLC | 40,000 | $87,200 | 0.00% |
| Banque Cantonale Vaudoise | 11,900 | $26 | 0.00% |
| WELLS FARGO & COMPANY/MN | 6,201 | $13,517 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 213,023 | $464,390 | 0.00% |